RNAi Screening Libraries
Invitrogen™ Silencer™ Select Human Long Non-coding RNA (lncRNA) siRNA Library
The Silencer™ Select Human Long Noncoding RNA (lncRNA) siRNA Library contains 15,081 Ambion™ Silencer Select siRNAs targeting 5,027 lncRNAs as identified in GENCODE v22.
Invitrogen™ Silencer™ Select Human Kinase siRNA Library V4
Silencer™ Select Human Kinase siRNA Library V4
Invitrogen™ LentiArray™ Human Protease CRISPR Library
The Invitrogen™ LentiArray™ Human Protease Library targets 475 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 1,900 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ LentiArray™ Human GPCR CRISPR Library
The Invitrogen™ LentiArray™ Human GPCR Library targets 446 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 1,784 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ LentiArray™ Human Tumor Suppressor CRISPR Library
The Invitrogen™ LentiArray™ Human Tumor Suppressor Library targets 716 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 2,864 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ Silencer™ Select Human Cell Cycle Regulation siRNA Library
Proteins that regulate cell division are crucial for controlling cell growth and are therefore potentially important drug targets.
Invitrogen™ Silencer™ Select Human Membrane Trafficking siRNA Library
The Silencer™ Select Human Membrane Trafficking siRNA Library is designed for researchers targeting proteins known or predicted to participate in membrane trafficking or remodeling.
Invitrogen™ Silencer™ Human Cell Cycle Regulation siRNA Library
Proteins that regulate cell division are crucial for controlling cell growth and are therefore potentially important drug targets.
Invitrogen™ Silencer™ Human Cancer Genome siRNA Library
The Silencer™ Human Cancer Genome siRNA Library contains 1572 Ambion™ Silencer siRNAs targeting 524 gene targets that are commonly affected in cancers.
Invitrogen™ Silencer™ Select Human Tumor Suppressor siRNA Library
Mutations that cause a loss or reduction in gene function can result in the progression to cancer, usually in combination with other genetic changes. Tumor suppressor genes, or anti-oncogenes, can protect cells on the path to becoming cancerous.
Invitrogen™ Silencer™ Human Apoptosis siRNA Library
The Silencer™ Human Apoptosis siRNA Library provides investigators with a focused siRNA screening platform targeting apoptosis genes and enabling a detailed analysis of the apoptotic signaling pathway.
Invitrogen™ Silencer™ Human DNA Damage Response siRNA Library
DNA surveillance proteins monitor DNA integrity, and they can activate cell cycle checkpoints and DNA repair pathways in response to DNA damage. This can prevent potentially deleterious mutations.
Invitrogen™ Silencer™ Select Human Apoptosis siRNA Library
The Silencer™ Select Human Apoptosis siRNA Library provides investigators with a focused siRNA screening platform targeting apoptosis genes and enabling a detailed analysis of the apoptotic signaling pathway.
Invitrogen™ Silencer™ Select Human Phosphatase siRNA Library V4
For the first time, you can obtain the benefits of Ambion™ Silencer™ Select siRNAs in a convenient pre-plated, library format.
Invitrogen™ Silencer™ Human Kinase siRNA Library
Given their importance in cell signaling and many other biological pathways, kinases have become key drug targets.